Nanoscale imaging of proteins and nucleic acids via expansion microscopy

US10364457B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10364457-B2
Application numberUS-201615229539-A
CountryUS
Kind codeB2
Filing dateAug 5, 2016
Priority dateAug 7, 2015
Publication dateJul 30, 2019
Grant dateJul 30, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention enables in situ genomic and transcriptomic assessment of nucleic acids to be conducted in biological specimens that have been physically expanded. The invention leverages the techniques for expansion microscopy (ExM) to provide new methods for in situ genomic and transcriptomic assessment of nucleic in a new process referred to herein as “expansion fluorescent in situ hybridization” (ExFISH).

First claim

Opening claim text (preview).

What is claimed is: 1. A method for in situ genomic and transcriptomic assessment of target nucleic acids present in a biological sample comprising the steps of: a) treating the biological sample with a small molecule linker comprising a chemical reactive group capable of covalently binding at least one target nucleic acid and a chemical group that can be incorporated into the a swellable material; b) permeating the biological sample with a composition comprising precursors of a swellable material; c) initiating polymerization of the precursors to form a swellable material, wherein the small molecule linker is bound to the at least one target nucleic acid in the biological sample and to the swellable material; d). subjecting the biological sample to a physical disruption method; e). swelling the swellable material to form an expanded biological sample; f). providing at least one oligonucleotide complementary to the at least one target nucleic acid, wherein the at least one oligonucleotide hybridizes to the at least one target nucleic acid; and g). genomically or transcriptomically assessing the expanded biological sample. 2. The method according to claim 1 , wherein the small molecule linker is labeled. 3. The method according to claim 2 , wherein the expanded biological sample expresses one or more labeled target nucleic acids. 4. The method according to claim 1 , wherein the at least one oligonucleotide is labeled. 5. The method according to claim 1 , wherein the at least one target nucleic acid is anchored to the swellable material. 6. The method according to claim 1 , wherein the physical disruption method is an enzymatic digestion. 7. The method according to claim 1 , wherein the target nucleic acids are DNA and/or RNA. 8. The method according to claim 1 , further comprising the additional step of buffering the expanded sample. 9. The method according to claim 8 , further comprising the additional step of re-embedding the buffered expanded biological sample in a non-swellable material. 10. The method according to claim 9 , further comprising the step of removing the at least one oligonucleotide complementary to the at least one target nucleic acid. 11. The method according to claim 10 , wherein the steps of providing at least one oligonucleotide, genomically or transcriptomically assessing the expanded biological sample and removing the at least one oligonucleotide are repeated so as to allow serial or sequential genomic or transcriptomic assessments of the expanded biological sample. 12. The method of claim 10 , wherein removing the at least one oligonucleotide which is hybridized to the at least one target nucleic acid comprises formamide and high temperatures. 13. The method of claim 10 , wherein removing the at least one oligonucleotide which is hybridized to the at least one target nucleic acid comprises endonucleases that specifically digest the at least one oligonucleotide.

Assignees

Inventors

Classifications

  • Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • Embedding or analogous mounting of samples · CPC title

  • C12Q1/6841Primary

    In situ hybridisation · CPC title

  • using resins, epoxy · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10364457B2 cover?
The invention enables in situ genomic and transcriptomic assessment of nucleic acids to be conducted in biological specimens that have been physically expanded. The invention leverages the techniques for expansion microscopy (ExM) to provide new methods for in situ genomic and transcriptomic assessment of nucleic in a new process referred to herein as “expansion fluorescent in situ hybridizatio…
Who is the assignee on this patent?
Massachusetts Inst Technology, Harvard College
What technology area does this patent fall under?
Primary CPC classification C12Q1/6841. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).